Test directory: HPV High Risk PCR 16/18 Genotype

Ordering Code7707
Test NameHPV High Risk PCR 16/18 Genotype
AliasHuman Papillomavirus (HPV), High Risk with 16 and 18
Genotype by PCR, SurePath
HPV High Risk
HPV HR SurePath
Optimum Volume3 mL
Handling InstructionsSpecimen source required.
Transport RequirementsOahu: Refrigerated
Airline: Refrigerated
Specimen StabilityAmbient: 1 Month
Refrigerated: 6 Months
Frozen: Not Stable
Rejection CriteriaBloody or dark brown specimens, Specimens collected in other media
Avail. StatNO
Analytic Time10 Days
MethodologyQualitative Polymerase Chain Reaction
Reference Lab ARUP Laboratories

Reference range(s)

The reference ranges listed below are valid on this date of April 23, 2024.
ComponentAgeMale NormMale Critical LowMale Critical HighFemale NormFemale Critical HighFemale Critical LowUnitsAdd'l info
HPV SourceALLSee report.
HPV Genotype 18 by PCRALLSee report.
HPV Genotype 16 by PCRALLSee report.
HPV, Other High Risk by PCRALL

This test...
This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances
Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types, the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21

See report.
Note1

Note1:


This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances
Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types, the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21

See report..